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The interaction ofvirus with attachment sites on target cells isan important com-
ponent in determiningviral tropism and pathogenicity. Demonstration ofthebinding
ofseveral mammalian viruses, as for example HIV (1), to membrane proteins that
perform critical physiological functionshas focused attentiononthe moreimmediate
and direct consequences ofvirus-receptor interactions. The mammalian reoviruses
provide a particularly useful model for examining the means by which viruses can
utilize specific membrane proteins as vectorsofboth selective attachmentand patho-
genesis.
The threereovirus serotypes displaydistinct patterns oftropism that are controlled
in part by interaction ofthe virus outer capsid protein a1, which also serves as the
hemagglutinin (HA)', with apparently unique cellular attachment proteins (2-4).
Gene segment reassortants ofreovirus have been used in studies ofcentral nervous
system tropismto demonstrate that viruses that bear the serotype 3 HA (HA3) bind
neurons causing an often fatal neonatal encephalomyelitis while those expressing
serotype 1 HA (HAI) bind ependymal cells resulting in hydrocephalus (5). The cel-
lular attachment protein for type 3 virus is a 67-kD glycoprotein that bears struc-
tural and antigenic similarity to mammalian ß adrenergic receptors (4, 6). These
studies have been aided by the isolation of mAb antireovirus type 3 receptor anti-
body that was selected on the basis ofidiotypic mimicry ofthe HA3 (7). This anti-
body competes with type 3 virus and binds to the 67-kD receptor glycoprotein (4).
The theoretical rationale of this approach has been recently reviewed (8).
The serotype ofreovirus HA has also been directly linked to perturbation ofhost
cell physiology. Infectionofmouse L cells by reovirus type 3 results in potent inhibi-
tion ofhost cell DNA synthesis (9). Inhibition is first detected at 8-10h postinfection
before any cytopathic effects (10). By 24 h, DNA synthesis in infected cells is only
15-25% ofcontrols (9). Inhibition is manifest as a blockade ofmultifocal initiation
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of new DNA chain synthesis on replication units resulting in an accumulation of
cells in G1 phase (11-14). In contrast to these observations, the binding of type 1
virus to this same cell line has little or no effect on DNA synthesis (9). Using molec-
ular reassortants, Sharpe and Fields (9) have shown that inhibition of DNA syn-
thesis is dependent on the presence of HA3 . The mechanism ofDNA synthesis inhi-
bition in response to HA3 binding remains in question. Studies usingeither inactivated
virus or viral capsid components have yielded conflicting results (15, 16). The pos-
sible mechanism for these effects included a direct, receptor-mediated effect on DNA
synthesis after virus (HA3) binding, or intracellular effects of HA3 protein or St
transcripts on synthetic machinery.
To more fully examine the mechanism of reovirus inhibition of DNA synthesis
and to gain a better understanding of reovirus pathogenicity toward cells of the cen-
tral nervous system, we have studied the effects of reovirus and antireceptor anti-
body on the rat neuroblastoma cell line B104 .G4. The addition of reovirus type 3
and HA3 containing virus reassortants caused potent inhibition of DNA synthesis
in B104.G4 cells. Inhibitionwas observed using replication-defective virus and when
intracellular virus processing, but not binding, was blocked by lysosomotrophic agents.
Antireceptor antibody mimicked intact virus in the inhibition of DNA synthesis.
Inhibition was dependent upon the presence ofintact antibody or when monovalent
F(ab) fragments were crosslinked by anti-Ig. The inclusion of ß adrenergic agonists
and antagonists had no effect on DNA synthesis in the presence or absence of virus.
Therefore, inhibition of cellular DNA synthesis by reovirus type 3 occurs through
a direct, receptor-triggered event that involves microaggregation but not intracel-
lular processing of receptor molecules. These results also suggest that naturally oc-
curring antiidiotypic, antireovirus receptor antibodies can have potent autoimmune
effects in the central nervous system.
Materials and Methods
Tissue Culture.
￿
The neuroblastoma lines NB41A3 and Neuro 2A were obtained from the
American Type Culture Collection (Rockville, MD). Neuroblastoma B104.G4 was derived
from parental B104 cells (a gift ofDr. Jeff Drebin, Johns Hopkins University, Baltimore, MD)
by selection ofisolated clones for acute sensitivity to reovirus inhibition of DNA synthesis.
All cells were grown at 37°C in 5% C02 in monolayer using DMEM (KC Biological, Inc.,
Lenexa, KS) supplemented with 100 1o FCS, lojo pen-strep-fungizone mixture (M. A. Bio-
products, Walkersville, MD), and 100 ug/ml gentamycin sulfate (M. A. Bioproducts). mAb
hybridoma lines 87 .92.6 and 61.21.18 were maintained in RPMI 1640 (KC Biological, Inc.)
supplemented as above.
Virus.
￿
Reovirus type 3 (Dearing), 1 (Lang), 1HA3, and 3HA1 were obtained from Dr.
Virginia Hinshaw (Harvard University, Boston, MA). Virus was grown on murine L-929
cells and purified by CsCl gradients as previously described (17, 18). Serotype analysis was
performed using a panel of mAbs and by polyacrylamide gel analysis of the dsRNA (17).
The infectioustiterofvirus was determined by plaque analysis (plaque-forming units [PFU])
on L-929 monolayers. Preparation of UVinactivated virus was performed at 11 ergs/s/mm2
as described by Shaw and Cox (19) . Inactivation was verified by titer analysis on L-929 cells.
Binding of inactive virus was verified by immunostaining as described below.
Measurement ofDNA Synthesis.
￿
B104.G5 cells were seeded into 96-well plates (Costar, Cam-
bridge, MA) at 5 x 10¢ cells/well in 200 pl. After a minimum of 12 h, virus was added at
30 PFU/cell for 60 min at 37°C. Cells were then washed into fresh DMEM with supplements
and recultured for the times indicated. Cells were pulsed with [3H-methyl]thymidine (20
Ci/mmol; New England Nuclear, Boston, MA) for the final 6 h of culture, after which reac-GAULTON AND GREENE
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tions were stopped by the addition of trypsin-versene (M. A. Bioproducts) and freezing at
-20°C for a minimum of 60 min. Cells were thawed and the DNA was collected onto glass
fiber filters using a PHD cell harvester (Cambridge Technology, Inc., Cambridge, MA). Filter
discs were analyzedby scintillation counting. Fordrug inhibition studies cells were incubated
with either monensin, chloroquine, ammonium chloride, or methylamine (Sigma Chemical
Co., St. Louis, MO) at the concentrations indicated in the text for 60 min before, coincident
with, and subsequent to virus addition. No effect of these agents on the binding of reovirus
was detected at any of the concentrations used. Toxicity was assessed by the exclusion oftrypan
blue dye as judged by microscopic analysis, and by measurement of the level of DNA and
protein synthesis using radiolabeled precursors.
Measurement of Virus Binding and Macromolecule Synthesis.
￿
Virus binding experiments were
conducted by immunofluorescence staining and analysis on a flow cytofluorimeter. Cells were
harvested from monolayer using buffered EDTA (Versene; M. A. Bioproducts), then washed
three times in FAGS medium (20 mM sodium phosphate [pH 7.4], 150 mM NaCl, 2, horse
serum, and 0.2% sodium azide). 105 cells were incubated with virus at 50 PFU/cell for 45
min at 4°C, washed extensively, and bound virus was detected by the addition of 2 jig avidin-
coupled antivirus antibody in 100 wl for 45 min at 4°C. Avidin antibody was prepared using
highly purified (>98% by gel analysis) rabbit antireovirus Ig that was biotinylated and then
pre-mixed with a 1 :20 dilution of avidin-fluorescein (Becton Dickinson & Co., Mountain
View, CA). High titer antireovirus type 3 Ig was prepared by immunization with type 3 but
shows substantial crossreactivity to type 1 virus as determined by both immunoprecipitation
and fluorescence binding analysis on infected L-929 cells (not shown). Cells were washed
free of unbound label and 104 cells/sample were analyzed on a FACS analyzer (Becton Dick-
inson & Co.).
As an indication of virus replication at early time points (<24 h), virus-specific macro-
molecule synthesis was determined by immunoprecipitation analysis of radiolabeled viral
proteins from infected cell extracts. B104.G4 cells were seeded onto 6-well culture plates (Costar)
at 106 cells/well. After a minumum of 12 h, virus was added at 30 PFU/cell for 60 min at
37°C . Cells were washed and recultured in supplemented DMEM for 18 h. At this time cells
were again washed and fed with methionine-free DMEM (KC Biological, Inc.), and then
incubated with 100 gCi/ml [35S]methionine (950 Ci/mmol; New England Nuclear). Cells
were harvested for immunoprecipitation after 6 h by the addition of 500 Al of detergent lysis
solution (1% Triton X-100, 0.5% NP-40, 10 mM iodoacetamide, 2 mM PMSF, 150 mM NaCl,
and 20 mM sodium phosphate fpH 7 .2]). Samples were incubated on ice for 30 min then
clarified by centrifugation at 35,000 g for 30 min. Reovirus protein synthesis was determined
by immunoprecipitation in the presence of purified polyclonal antireovirus antibody con-
jugated to sepharose beads (40 wl of a 1 mg/ml bead suspension) for 45 min at 4°C. Im-
munoprecipitates were harvested by centrifugation and washed extensively in detergent lysis
solution containing 0.5 M NaCl before measurement of counts bound by liquid scintillation
counting.
Antibody Isolation and BindingAnalysis.
￿
mAb 87.92.6 (murine IgM,k) and 61.21.18 (murine
IgM,k), and polyclonal rabbit antireovirus receptor were purified by affinity chromatography
as previously described (20). mAb OX-18 (murine anti-rat MHC) was purchased from Bio-
products for Science (Indianapolis, IN) and purified as above. Purified rabbit anti-mouse
Ig was a gift of Dr. John Monroe (University ofPennsylvania, Philadelphia, PA). Antibody
purity was verified by silver stain of samples run on SDS-PAGE, Iodination of purified anti-
bodies (25 gg/reaction) was performed according to Hunter (21) in the presence of chlora-
mine T and 250 gCi Na1251 (New England Nuclear). Labeled proteins were separated from
free label by passage over a mixed bed of Sephadex G50, DEAE cellulose, and Amberlite
IRA-400 (Sigma Chemical Co.). sp act of labeled mAb was 1.3 x 106 cpm/gg and >97%
of label was precipitated by 10% TCA. Binding studies were performed in 50-ul aliquots
containing 106 cells in PBS with 0.5% bovine albumin and 0.2% NaN3 as described (22).
Labeled mAb was mixed with cold ligand to achieve a final concentration of 10- 7-10- " M
and incubated at 4°C for 60 min. Bound label was separated from free by centrifugation
through phthalate oils (23) and cell-associated counts determined by gamma counting. Results
were analyzed according to the methods of Scatchard (24) using the criteria of Klotz (25).200
￿
IDIOTYPIC MIMICRY OF RECEPTOR SIGNALING
F(ab) fragments of mAb were prepared by the procedure of Bidlack and Mabie (26) at
pH 8.1 using trypsinTPCK. Fragments were purified by sequential affinity and molecular
sieve chromatography. mAbs were coupled to CnBr-activated sepharose beads at a density
of 1 mg/mlaccordingto the instructions supplied by the manufacturer (Pharmacia Fine Chem-
icals, Piscataway, NJ).
Results
Serospecificity of Reovirus Binding and DNA Inhibition in Neuroblastoma Cells.
￿
To es-
tablish an in vitro model for evaluatingthe effects of reovirus within the central nervous
system, we have investigated the binding patterns and physiological consequences
ofvirus infection in a panel of rodent neuroblastoma cell lines, including Neuro-2A,
NB41A3, and B104.G4. The binding of reovirus serotypes 1 and 3 to these lines was
investigated using microfluorometric analysis. Cells were incubated with virus, as
indicated in Fig. 1, followed by the addition ofbiotin antivirus antibody/avidin-fluores-
cein complex and detection using a fluorescence-activated flow cytometer. In agree-
ment with previous analysis of infectivity patterns in vivo (5), each of the three neu-
ronal lines tested displayed a selective binding of type 3 reovirus over type 1. No
increase in antibody binding was detected in type 1 virus-treated cells as compared
with controls conducted in the absence of virus or using an irrelevant antivirus (an-
timeasles) antibody. The highest level oftype 3 binding was detected on the B104.G4
line. Previous studies using antireceptor antibody showed that the parental B104
line contained 78,000 type 3 receptors per cell (4).
Analysis of the pathogenetic effects of reovirus type 3 on B104.G4 cells was initi-
ated by examining virus-induced DNA inhibition. The addition of reovirus type
3 or the recombinant virus 1HA3, which contained the type 3 HA on the back-
ground of a type 1 virus, resulted in inhibition of B104.G4 DNA synthesis (Fig. 2).
By 48 h after infection, levels of synthesis were 22% of control (type 1) values. The
timing of inhibition lagged behind that described in murine L cells that were max-
imally inhibited by 24 h (9). The addition oftype 1 virus or the recombinant 3HA1,
which contained the type 1 HA on a type 3 background, had no effect on DNA
synthesis relative to untreated cells (not shown). Type 3 virus, which was UV irradi-
ated so as to abolish its infectivity, but not binding, still blocked DNA synthesis.
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FIGURE 1.
￿
Bindingof reovirus serotypesto neuroblastoma lines. Therelative degree of binding
of reovirus serotypes to neuroblastoma lines B104.G4 (A), NB41A3 (B), and Neuro 2A (C) was
examined by microfluorometric analysis. Cells were first incubated with either buffer (1), reo-
virus type 1 (2), or reovirus type 3 (3 and 4). The level of virus binding was then determined
by the addition of either polyclonal antireovirus 1-3 (1, 2, and 4) or control, antimeasles (3) anti-
body. Both antibody preparations were bound to biotin and indirectly coupledto avidin-fluores-
cein. The amount of binding was measured on afluorescence-activated flow cytometer. Results
are expressed as cell number vs. relative fluorescence intensity.s0
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FIGURE 2.
￿
Effect of reovirus serotype on inhibition ofDNA
synthesis in B104.G4 cells. The effects ofreovirus on B104G4
DNA synthesis was investigated using the viruses: type 3
(O), type 1 (A), recombinant 1HA3 ("), recombinant3HA1
(/), UVinactivated type 3 virus (A), or type 3 virus in
the presence of neutralizing antibody (EI). B104G4 cells
were seeded in subconfluent monolayers in microtiter wells
at 5 x 104 cells in 200 ji1. Cells were incubated with 30
PFU/cell of virus, or an equivalent particle number ofUV
inactivated virus, for 60 min at 37°C to allow virus attach-
ment. Cells were washed into fresh medium and incubated
for the times indicated. To measure DNA synthesis cells were
pulsed with 1 gCi/well of [3H]thymidine for the last 6 h of
culture, and DNA was harvested on glass fiber filter discs
and counted using a scintillation cocktail.
In contrast, addition of high-titer neutralizing antibody abolished the type 3 effect.
Therefore, these observations confirm that inhibition ofDNA synthesis in neuronal
cells is HA3 linked and is independent from reovirus replication.
Inhibition of Virus Processing Does notAffect DNA Inhibition.
￿
Reoviruses are distin-
guished by their use of lysosomal processing as a means for uncoating the double
capsid viral particle to yield an infective viral core, termed the subviral particle (27).
Virus receptor complexes are first taken into phagocytic vacuoles that rapidly (30-60
min) fuse with lysosomal vesicles (28). Uncoated subviral particles enter the cytoplasm
apparently by direct penetration of the lysosomal membrane and begin the replica-
tive phase (29). The relative importance of receptor attachment vs. internalization
of viral particles in the mechanism of inhibition of DNA synthesis was investigated
using lysosomotrophic agents that block virus entry and/or processing in target
cells (30).
A panel of drugs that disrupt lysosomal function were first screened for effects
on basal DNA and protein synthesis, and the ability to block virus replication in
B104.G4 cells (Fig. 3 A) . The concentrations of drugs used are the maximal doses
at which no inhibitory effects were observed on basal synthesis of macromolecules.
The level of virus replication during the first 24 h of infection was determined by
measuring virus-specific protein synthesis. This was achieved by immunoprecipita-
tion ofviral proteins from 35S-methionine pulse-labeled cells using an antireovirus
antisera. A fourfold increase in immunoprecipitable viral proteins was detected in
infected vs. noninfected or antibody controls (Fig. 3 A). The addition of 10-15 mM
NH4C1 or 5 x 10-4 M chloroquine 60 min before and coincident with virus com-
pletely abrogated viral protein synthesis without effect on basal protein synthesis.
In contrast to these results, at decreasing concentrations of chloroquine (10 -s-10-b
M) and the highest nontoxic concentration of monensin (10-6 M) and methylamine
(1 mM, not shown), significant viral protein synthesis was detected. These concen-
trations and drugs were therefore not used in the remaining studies. The effects of
ammonium chloride and chloroquine, at concentrations that blocked viral replica-
tion, on virus-induced DNA inhibition is presented in Fig. 3 B. In each instance
agents that blocked virus replication were without effect on reovirus-directed inhibi-
tion of DNA synthesis .202
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FIGURE 3 .
￿
Effects of inhibitors
of lysosomal processing or traf-
ficking on virus replication and
inhibition o£DNA synthesis . (A)
Effects of drugs on virus repli-
cation . Subconfluent monolayers
of B104.G4 cells (10' cells/con-
dition) were incubated with
media or either of the com-
pounds (ammonium chloride,
chloroquine, or monensin) at
the concentrations listed for
60 min before the addition of
buffer control (light bars) or type
3 reovirus (30 PFU/cell; dark
bars) . After 60 min unbound
virus was withdrawn and cells
were recultured in media in the
presence of these same inhibi-
tors . Cells were incubated for
18 h and then pulsed with ("Sl-
methionine for an additional 6
h . The level ofreovirus protein
synthesis was determined by
immunoprecipitation of deter-
gent-lysed cell extracts using an-
tireovirus sepharose beads . (B)
Effects of drugs on reovirus in-
ducedDNA inhibition . B104.G4
cells were treated with virus and
drugs as described in A and
pulsed with [ 3Hlthymidine for
the final 6 h of a 24-h culture .
DNA synthesis was determined
by harvesting cell extracts onto
glass fiber filters and measuring
thymidine incorporation by scin-
tillation counting . Results pre-
sented represent the mean ±
SE ofexperiments performed in
triplicate. (') p < 0.001 by
paired t test .
Antireceptor Antibodies Mimic Virus Inhibition ofDNA Synthesis .
￿
Antireceptor anti-
bodies that serve as internal images ofthereovirusHA3have been isolated andcharac-
terized . These antibodies were selected as anti-(anti-HA3)idiotypes (7, 31), and mimic
the effects of HA3 by both immunologic and biochemical criteria . Antiidiotypes
stimulate anti-HA3-specific B and T cell-mediated immune responses across spe-
cies barriers (20) . Antiidiotypes bind to cells in an HA3-restricted fashion, compete
with intact virus for cell surface attachment, and immunoprecipitate the same 67-
kD glycoprotein as type 3 virus (4, 22) .
The effects of polyclonal and mAb antireceptor antibody on DNA synthesis in
B104.G4 cells is presented in Fig. 4 . The addition of purified rabbit polyclonal or
murine monoclonal (mAb 87 .92.6) antireceptor antibody at 100 fag/ml induced po-
tent inhibition ofDNA synthesis . The kinetics of this effect were indistinguishable
from that induced by intact reovirus type 3 . Significant differences in DNA syn-
thesis relative to controls was detected at 24 (p < 0 .005), 48, and 72 (p < 0.001) h .w
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FIGURE 4.
￿
Inhibition ofDNA synthesis by antireceptor an-
tibody The effects ofantibodyon DNA synthesis in B104.G4
cells was determined as described in Fig. 2. Antibody or
virus was first incubated with cells for 60 min at 37°C then
washed and recultured for the times indicated. Cells were
*
￿
pulsed with I'H]thymidine for 6 h before assay. Reovirus
type 3 (O) and recombinant virus 3HA1 (/) were added
at 30 PFU/cell. Polyclonal rabbit antireovirus receptor(*),
mAb 87.92.6 antirecepfor (0), mAb 61.21.18 isotype con-
trol (A) and mAb OX-18 anti-MHC (A) were purified and
incubated at 100 kg/ml.
72
Controls included virus 3HA1, the isotype-matched nonbinding mAb 61.21 .18, and
mAb OX-18 an anti-rat MHC binding antibody. These results confirm the hypoth-
esis that engagement and/or perturbation of virus receptors and not virus-encoded
function is the key event in inhibition of DNA synthesis by reovirus type 3. Interest-
ingly, the level of inhibition with antibody was significantly less than that seen with
virus at the 48- and 72-h time points. Preliminary data indicate that antibody-treated
cells begin to recover from inhibition after 2-3 d. This is in marked contrast to virus-
infected B104.G4 cells that undergo viral cytolysis at 3-5 d. These observations point
out a potentially important consequence of the generation ofantiidiotypic, antirecep-
tor antibody in the course of normal antivirus immune responses.
The concentration dependence of mAb antireceptor antibody on the inhibition
of DNA synthesis in B104.G4 cells is sigmoidal (Fig. 5 A). This in part reflects the
concentration dependence of mAb binding, which is also presented in Fig. 5 A. mAb
antireceptor showed linear and saturable binding to B104.G4 over an N3-log dose
range of 5 x 10 - '-l x 10- 7 M mAb. The apparent Kd was 2 x 10-1 M as deter-
mined by Scatchard analysis of binding data (not shown) in good agreement with
previously published results on other receptor-positive lines (4, 22). Comparison of
the dose dependence of antireceptor antibody inhibition to that ofantibody binding
provides a clue to the mechanism of the inhibitory process. Inhibition of DNA syn-
thesis was not detected below a concentration of 2.5 x 10" 9 M antibody (Fig. 5 A),
yet at this concentration, 43% ofvirus receptors were already occupied. A compar-
ison of the extent of DNA inhibition vs. receptor occupancy (percent of receptor
bound by mAb), shown in Fig. 5 B, illustrates that inhibition occurred over a high
concentration and narrow range of bound antibody, e.g., 10% inhibition was seen
at 50% receptor occupancy, and 50% inhibition was seen at 70% occupancy. These
data suggest that inhibition results when a critical threshold of signal is attained
(antibody agonist) or lost (antibody antagonist), and/or that the simultaneous en-
gagement of multiple receptors is required for signal transmission.
Receptor Aggregation Is Requiredfor Inhibition of DNA Synthesis.
￿
Requirements for
aggregation of multiple receptors by antireceptor antibody were directly assessed
by examining DNA synthesis in the presence of monovalent F(ab) fragments of an-
tireceptor mAb and of secondary crosslinking agents such as anti-Ig on intact mAb204
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Comparison ofthe extent ofantibody
binding to the level ofDNA inhibition. (A) mAb
binding and DNA inhibition concentration de-
pendence. The dose dependence ofDNA inhibi-
tion at 48 h by rnAb antireceptor antibody was
conducted as described in Fig. 4 in the presence
of antibody concentrations of 10- "-10-' M (O).
mAb binding analysis was conducted by incuba-
tion of 106 B104G4 cells with increasing concen-
trations of 12,51-labeled mAb in 50 ul PBS/0.5%
bovine albumin/0.2 % sodium azide. After 60 min
at 4°C, cells were washed free of unbound label
by centrifugation through phathlate oils and
bound mAb was determined in a gamma counter.
Values presented (") were corrected for non-
specific binding, which was measured in the pres-
ence of a 100-fold excess of unlabeled mAb. (B)
Plot of receptor occupancy vs. extent ofDNA in-
hibition. The percentage of maximal DNA inhi-
bition by mAb antireceptor observed at 48 h was
calculated based on 74% inhibition at 10-7 M
mAb. The percentage of receptor occupancy by
mAb was calculated based on 100% occupancy
at an mAb concentration of 10-7 M.
and F(ab) fragments. Results presented in Fig. 6 show that the addition of 10-8 M
antireceptor mAb induced significant DNA inhibition while mAb at 10-9 M had
no effect. The addition of 10 wg rabbit anti-mouse Ig to these cultures had potent
effects. Inhibition was augmented in cultures containing 10-8 M mAb to a level
equivalent to that seen upon virus addition. Interestingly, the addition of anti-Ig
also stimulated maximal inhibition in cultures with 10-9 M mAb, where no inhi-
bition was previously observed despite 41% receptor occupancy.
Reciprocal analysis of these effects was conducted using monovalent F(ab) frag-
ments of antireceptor mAb. As shown in Fig. 6, F(ab) fragments had no effect on
DNA synthesis even when administered at 10 times (10- 7 M) the intact antibody
concentration. Binding ofthese fragments to cells at >70% receptor occupancy was
verified by radiolabeled binding analysis as described previously (data not shown).
The addition of anti-Ig to these cultures resulted in maximal inhibition of DNA
synthesis. Similar results were obtained when F(ab) fragments were rendered mul-
tivalent by conjugationathigh density to sepharosebeads. Controls conductedusing
whole or F(ab) fragments ofthe c-11 surface binding mAb OX-18 uniformly had no
effect, even when incubated in the presence of anti-Ig. These results confirm that
mAb binding alone does not initiate the inhibitory process and that aggregation
of multiple virus receptor proteins is required.
Estimation of the role played by accumulation of receptor second messengers is
more obtuse. An analysis of the kinetics of antibody receptor binding and signal
transmission is presented in Fig. 7. In this experiment antibody was first bound to
cells in the cold at 5 x 10-8 M, which saturates virus receptors. Cells were thenó
á
c
Q
z
0
É .x
m
E
100
75
50
25
i i i i i
￿
i ~z I
0 0.25 0.5 0.75 1 .0
￿
2 .0
￿
24
Time antibody bound (hours)
GAULTON AND GREENE
￿
205
shifted to 37°C and incubated for the times indicated . At these points bound anti-
body was removed by rapid (1 min) washing inDMEM containing 25 mM sodium
acetate (pH 4.0) . Cellswere quicklywashed into fresh mediaand recultured for48 h
at which time the level ofDNA synthesis was measured . Under these conditions
>90% ofboundmAb is removed from the cell surfacewithout toxic effects on cells .
As shownin Fig. 7, maximal inhibition wasobservedwhen antibody remained bound
forat least 30-60 minat 37 1C . Inclusion ofmAb forlonger periods, up to the entire
length of the assay (48 h), failed to augment the inhibitory effects of suboptimal
concentrations ofmAb . The same pattern was observed when 5 x 10-9M antibody
was bound despite the fact that only 45% inhibition was obtained . When mAb-cell
o---7~/_-o
FIGURE 6 . Requirements for
virus receptor aggregation in
the inhibition ofDNA synthesis .
Assays forDNA synthesis were
conducted essentially as de-
scribed in Fig. 4. Reovirus type
3 was added at 30 PFU/cell as
described previously. Whole
mAb or F(ab) fragments were
added to cells at the concentra-
tions listed for 60 min at 4°C .
Where noted, rabbit anti-mouse
Ig (10 vg/well) was included for
an additional 60 min. F(ab)-
sepharose bead conjugates were
included in some wells at acon-
centration of 20 vl of a 1-mg
F(ab)/ml beadsuspension. After
virus or antibody treatment,
cells were washed and recul-
tured in DMEM with supple-
ments at 37°C for standard
thymidine incorporation assay
at 48 h . Data are presented as
themean t SE ofexperiments
performed in triplicate . (') p<
0.001 .
FIGURE 7 .
￿
Determination ofthe requirements formAb-
induced DNA inhibition . B104.G4 cells were prein-
cubated with either 5 x 10 - sM (O) or 5 x 10-9M (")
mAb for 60 min at 4°C. At t = 0, cells were shifted
to 37°C . At the times indicated cells were washed briefly
in pH 4.0 buffer to remove bound antibody and then
recultured for up to 48 h . As controls, cells were left at
4°C (A) or in the presence of 0.2% sodium azide (")
for the first 2 h after preincubation and then subjected
to acid washing. Thymidine incorporation assays were
conducted as described in Fig . 4 .206
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conjugates were left at 4°C or in the presence of the metabolic inhibitor sodium
azide for an additional 2 h after binding, there were no inhibitory effects. Two facts
can be deduced from this data. First, the induction ofDNA inhibition by antireceptor
antibody is an energy-dependent process; and second, if a threshold of signal is re-
quired, it occurs within the first 30-60 min after binding at 37°C . An additive signal
was not generated by increasing the incubation time of mAb bound at suboptimal
concentrations. These observations are consistent with a receptor aggregation sig-
naling model.
Involvement ofß Adrenergic Receptors in Inhibition ofDNA Synthesis.
￿
The biochemical
and immunological similarities of the mammalian reovirus type 3 and ß adrenergic
receptor families suggest the hypothesis that reovirus type 3 might utilize ß adren-
ergic or ß adrenergic-like signaling pathways as pathogenetic vectors. To test this
hypothesis we have investigated the capacity of virus and antireceptor antibody to
act as ß agonists, and the effects of well-established ß agonists and antagonists on
DNA synthesis in B104.G4. As shown in Fig. 8 A, the stimulation of cyclic AMP
accumulation in B104.G4 cells occured rapidly (15-30 s) in response to the ß adren-
ergic agonist (-)isoproterenol . In contrast, the continuous presence for 60 min of
type 3 reovirus or antireceptor antibody at concentrations that inhibit DNA syn-
thesis had no effect on cyclic AMP levels. Experiments performed in the presence
of 1 mM 3-isobutyl-l-methyl xanthine, a potent inhibitor of cyclic AMP phos-
phodiesterase, gave similar results (not shown).
The capacity of ß agonists to affect DNA synthesis of B104.G4 cells is presented
in Fig. 8 B. The addition of (-)isoproterenol at 10- s-10 -5 M had no effect on DNA
synthesis or on the inhibition ofDNA synthesis induced by virus or mAb. Inhibition
of DNA synthesis at concentrations of (-)isoproterenol >10 -4 M was the result of
toxicity as determined microscopically by dye exclusion. Similar results were ob-
tained in the presence of the ß agonists (-)epinephrine, (-)norepinephrine, and
A
FIGURE 8.
￿
Role of ß adrenergic receptors in inhibition of DNA
synthesis. (A) Accumulation of cyclic AMP in response to virus
receptor binding. Cyclic AMP formation in intact B104.G4 cells
was measured in the presence ofeither 10-1' M (-) isoproterenol
Time (minutes)
￿
(O), 30 PFU/cell reovirus type 3 ( "), 10- ' M mAb antireceptor
(A), or buffer (A) by RIA. (B) Effect of p agonists on DNA syn-
thesis in Bl04.G4. The effect of the agonist (-) isoproterenol at
concentrations of 10-5- 10-a M on DNA synthesis either alone
(O), or in the presence of 30 PFU/cell reovirus type 3 (" ) or 10-7
M mAb (A) antireceptor was measured as described in Fig. 4.
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(+)isoproterenol, and the ß antagonist (-)alprenolol (data not shown). These results
confirm that activation ofclassical ß adrenergic pathways is not involved in the mech-
anism of virus-mediated inhibition of DNA synthesis.
Discussion
The mammalian reoviruses provide a well-studied example of the complex pat-
terns and varied means by which viruses exert pathology. The ease of generating
reovirus reassortants that may differ in a single genomic segment has enabled corre-
lation of gene function to viral growth and interaction with host. These studies have
demonstrated that the al outer capsid protein plays a crucial role in the interaction
of reovirus at the organismal and cellular levels. al serves as the reovirus HA (32),
it is the primary factor in directing host immune responses (33-35), it specifies tissue
and cell tropism (4, 36), and affects neurovirulence (5, 36). At the cellular level it
determines the interaction of virus particles with microtubules (37) and regulates
cellular DNA synthesis (9).
The inhibition of DNA synthesis initiated by reovirus has been carefully described.
Inhibition is not related to an alteration in DNA precursor pools (19, 38), and occurs
without detectabledegradation ofcellular DNA (11). Rather, inhibition results from
a blockade of multifocal initiation of new chain DNA synthesis on replication units
(12, 13). This process is unrelated to general effects on host protein synthesis (10,
11, 39). The observation that inhibition of DNA synthesis is seen in virions with
type 3 HA but not those with type 1 HA suggested that the mechanism ofthis effect
resulted from the direct action of HA3 on target cells (9). This was supported by
observations that replication-defective UVirradiated virus-blocked synthesis-dnfctive
virion cores, which lack outer capsid, uniformly failed to cause inhibition (9, 15).
One conflicting result was that virus top component, empty capsid that contains
no nucleic acid, did not inhibit DNA synthesis (15, 16). However, only 20% of top
component bound to cells relative to intact virus (40).
The data presented in this study definitively link the processes of cellular tropism
and regulation of host cell macromolecule synthesis through the actions of the viral
HA on specific cellular membrane proteins. HA (HÁ3)-specific binding and inhibi-
tion of DNA synthesis was demonstrated on the neuroblastoma cell line B104.G4.
The essential role of virus attachment as contrasted to virus replication in the inhi-
bition of DNA synthesis was shown through the use of UV-inactivated virus and
drugs that block lysosomal processing and trafficking, which are essential to virus
replication. The ability of antireceptor antibodies to mimic viral inhibitory effects
confirmed that this pathogenesis was not virus encoded per se. It therefore appears
that reovirus type 3 binds to a physiologic membrane protein and induces the inhi-
bition of cellular DNA synthesis by either normal or aberrant signaling through
this molecule.
Several observations indicate that aggregation of multiple receptor molecules is
required for inhibition to occur. Inhibition was only seen when >50% of receptors
were bound by pentameric antireceptor mAb while the addition of anti-Ig to cells
with <50% receptor occupancy augmented inhibition. The level of inhibition in the
presence of anti-Ig was more pronounced in all conditions and was equivalent to
that seen with virus. Monovalent F(ab) fragments of antireceptor antibody were
ineffective, even when used at concentrations where 75-100% of surface receptors208
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were bound. Inhibitionwas restored when anti-Ig was added to bound F(ab) or when
multivalent F(ab)-sepharose beads were used. Finally, binding of mAb had no effect
when cells were maintained at 4°C but was effective when cellswere shifted to 37°C
for 30-60 min. Requirements for receptor aggregation fit nicely with previous data
obtained using virus preparations. Intact reovirus virions contain 48 HA mole-
cules/capsid (41) and therefore should engage multiple receptors upon cell contact.
Virus top component shows reduced binding and does not inhibit DNA synthesis,
and more pronounced inhibition is seen when virus is used at high multiplicity of
infection (42).
The interesting structural association between reovirus type 3 and O adrenergic
receptors may offer a clue as to how this effect is directed. Our preliminary studies,
however, indicate that classical O agonist pathways are not activated by virus or an-
tireceptor antibody. O adrenergic agonists and antagonists neither mimicked nor
blocked the effects of virus or mAb on B104.G4 cells. Receptor aggregation is not
associated with any known O adrenergic receptor function. Therefore, these obser-
vations suggest that any signaling via O receptors is through an aberrant pathway.
Crosslinking of O receptors using anti-O receptor-specific antibody will help to re-
solve this issue. These results are in agreement with those recently reported by Choi
and Lee (43) . Their investigation failed to detect any physical or functional associa-
tion of reovirus type 3 and O adrenergic receptors on A431 cells. Studies are presently
underway in our laboratories to directly assess reovirus and O receptor homology
at the biochemical and genetic levels .
An alternative possibility is that reovirus type 3 binds an as yet unreported 0-re-
lated receptor class. Sequencing ofreovirus receptor genesis essential to understanding
the degree of homology. The consequences of this interaction in terms of second
messengers activated are now being investigated. Preliminary data indicates that
inhibition is antagonized by agonists of cyclic adenosine monophosphate and that
antireceptor antibody binding enhances membrane-associated protein kinase activity.
The ability of antiidiotypic antibody to act as an internal image of virus raises
the possibility that some aspects of viral pathogenesis may be mediated by the en-
dogenous production of antiidiotypic antibodies in the course of a normal immune
response. The production ofantiidiotypic, antiacetylcholine receptor antibodies and
myasthenia gravis-like pathology in response to immunization with the acetylcho-
line receptor agonist BisQprovides a working model of this process (44, 45). More
detailed investigations are now being conducted in vivo to examine antiidiotype
pathology in reovirus type 3-infected mice.
Summary
Mammalian reovirus type 3 binds to a 67-kD surface glycoprotein on the mem-
brane of neuronal cells. This interaction initiates the infective reovirus cycle. The
physiological function of'this virus receptor is not known, however, initial studies
illustrate a striking structural and antigenic homology to the O adrenergic receptor
family. The earliest known pathologic effect of reovirus type 3 is an inhibition of
host cell DNA synthesis within 8-10 h after virus attachment. The studies reported
here demonstrate that binding and aggregation of reovirus receptor molecules pro-
vides the signal for this inhibitory process. Inhibition of DNA synthesis in the neu-
roblastoma cell line B104.G4 was unaffected by using replication-defective virus orGAULTON AND GREENE
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when lysosomal processing of normal virus was blocked. Inhibition was mimicked
by an antiidiotypic, antireceptor mAb. Inhibition was not observed when monova-
lent mAb fragments were bound to receptors, but was reconstituted when these frag-
ments were aggregated by the addition ofanti-Ig. The signal for the inhibitoryeffect
was generated within the first 60 min after mAb binding. These observations dem-
onstrate that reovirus and antiidiotypic pathogenicity can result from the perturba-
tion of membrane proteins that may perform normal physiological functions.
The authors are grateful to Dr. Virginia Hinshaw for supplying reovirus preparations.
Receivedfor publication 31 May 1988 and in revisedform 12 September 1988.
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